Rare Disease Market in APAC
- Changdeok Ji
- Feb 28
- 1 min read
I’ve recently put together an article on the rare disease sector, thanks to a suggestion from San Godhania, CEO of Partner Rare.
I hope you find it insightful!
Based on my experience in the rare disease field, I took a close look at how the market has changed over the past 20 years and where it’s headed. The article explores the evolution of the APAC market, covering both current and emerging markets. It also examines how advancements in diagnostic technologies and regulatory shifts are shaping market access.
Additionally, I’ve included some strategic recommendations for companies looking to navigate this complex landscape. If you’re interested in these insights, feel free to check out the full article. I’m sharing what I’ve learned with humility and hope it provides value.
Comments